Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-04-12 @ 10:47 PM
Study NCT ID:
NCT05164393
Status:
UNKNOWN
Last Update Posted:
2022-01-27
First Post:
2021-11-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Sponsor:
Coegin Pharma AB
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Actinic Keratoses | View |